Cargando…

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus

OBJECTIVE: To evaluate the effects of targeting Ikaros and Aiolos by cereblon modulator iberdomide on the activation and differentiation of B-cells from patients with systemic lupus erythematosus (SLE). METHODS: CD19(+) B-cells isolated from the peripheral blood of patients with SLE (n=41) were cult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivellese, Felice, Manou-Stathopoulou, Sotiria, Mauro, Daniele, Goldmann, Katriona, Pyne, Debasish, Rajakariar, Ravindra, Gordon, Patrick, Schafer, Peter, Bombardieri, Michele, Pitzalis, Costantino, Lewis, Myles J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970264/ https://www.ncbi.nlm.nih.gov/pubmed/33727237 http://dx.doi.org/10.1136/lupus-2020-000445

Ejemplares similares

Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
por: Schafer, Peter H, et al.
Publicado: (2018)

Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL
por: Hagner, Patrick R., et al.
Publicado: (2022)

Genetic Mapping and Allelic Loss Analysis in Mouse Thymic Lymphomas of Helios and Aiolos Belonging to the Ikaros Gene Family
por: Xu, Hongbin, et al.
Publicado: (2001)

Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis
por: Sciacca, Elisabetta, et al.
Publicado: (2022)

Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them
por: Cippitelli, Marco, et al.
Publicado: (2021)

Systematic Review and the External Validity of Randomized Controlled Trials in Lupus Nephritis
por: Pakozdi, Angela, et al.
Publicado: (2017)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Intermuscular adipose tissue in patients with systemic lupus erythematosus
por: Gamboa, Jorge Luis, et al.
Publicado: (2022)

Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
por: Arinuma, Yoshiyuki, et al.
Publicado: (2014)

Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
por: Han, Bobby Kwanghoon, et al.
Publicado: (2020)

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
por: Franssen, Laurens E., et al.
Publicado: (2018)

Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
por: Furie, Richard A, et al.
Publicado: (2022)

Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
por: Draborg, Anette Holck, et al.
Publicado: (2014)

Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis
por: Xiang, Shate, et al.
Publicado: (2022)

Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus
por: Hanly, John G, et al.
Publicado: (2022)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus
por: Maeda, Shinji, et al.
Publicado: (2023)

Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response
por: Boutet, Marie-Astrid, et al.
Publicado: (2021)

Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis
por: Jackman, Rachael P, et al.
Publicado: (2018)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
por: Neupane, Binod, et al.
Publicado: (2023)

nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high-dimensional data
por: Lewis, Myles J, et al.
Publicado: (2023)

Ultrasound detects subclinical joint inflammation in the hands and wrists of patients with systemic lupus erythematosus without musculoskeletal symptoms
por: Ruano, Carina A, et al.
Publicado: (2017)

Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN)
por: Gandhi, Anita K, et al.
Publicado: (2014)

Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
por: Bjorklund, C C, et al.
Publicado: (2015)

Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation
por: Nossent, Johannes C, et al.
Publicado: (2016)

Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections
por: He, Shuangjun, et al.
Publicado: (2021)

M3C: Monte Carlo reference-based consensus clustering
por: John, Christopher R., et al.
Publicado: (2020)

Aiolos and Lymphocyte Mimicry in Lung Cancer
por: Terada, Lance S, et al.
Publicado: (2014)

Aiolos regulates eosinophil migration into tissues
por: Felton, Jennifer M., et al.
Publicado: (2021)

Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre
por: Hill, Deanna D, et al.
Publicado: (2021)

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
por: Maslen, Toni, et al.
Publicado: (2021)

AIOLOS Variants Causing Immunodeficiency in Human and Mice
por: Yamashita, Motoi, et al.
Publicado: (2022)

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis
por: Boutet, Marie-Astrid, et al.
Publicado: (2020)

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
por: Rivellese, Felice, et al.
Publicado: (2022)

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
por: Lewis, Myles J., et al.
Publicado: (2016)

Mast Cells in Early Rheumatoid Arthritis
por: Rivellese, Felice, et al.
Publicado: (2019)

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors
por: Nerviani, Alessandra, et al.
Publicado: (2021)

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
por: Rivellese, Felice, et al.
Publicado: (2020)

Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells
por: Russell, Dayvia A, et al.
Publicado: (2020)

Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4(+) T Cell Metabolic Rewiring
por: Pucino, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hl3jrch4ggpf39qd61arit2s1q